tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Tourmaline Bio to be acquired by Novartis for $48.00 per share in cash
PremiumThe FlyTourmaline Bio to be acquired by Novartis for $48.00 per share in cash
2d ago
Novartis price target raised to CHF 105 from CHF 100 at Morgan Stanley
Premium
The Fly
Novartis price target raised to CHF 105 from CHF 100 at Morgan Stanley
2d ago
Novartis AG: Balancing Promising Pipeline Developments with Valuation and Risk Concerns
Premium
Ratings
Novartis AG: Balancing Promising Pipeline Developments with Valuation and Risk Concerns
7d ago
Novartis, BioArctic enter collaboration and license pact for BrainTransporter
PremiumThe FlyNovartis, BioArctic enter collaboration and license pact for BrainTransporter
16d ago
Novartis price target raised to CHF 120 from CHF 115 at Deutsche Bank
Premium
The Fly
Novartis price target raised to CHF 120 from CHF 115 at Deutsche Bank
20d ago
Trump Weekly: Trump weighs stake in Intel, candidates for Fed Chair
Premium
The Fly
Trump Weekly: Trump weighs stake in Intel, candidates for Fed Chair
26d ago
Novartis Achieves Milestone with Successful Phase III Trials for Sjögren’s Disease Treatment
PremiumCompany AnnouncementsNovartis Achieves Milestone with Successful Phase III Trials for Sjögren’s Disease Treatment
1M ago
Cullinan has positive read from Novartis data, says Clear Street
Premium
The Fly
Cullinan has positive read from Novartis data, says Clear Street
1M ago
Novartis trial has positive read for Zura Bio, says Guggenheim
Premium
The Fly
Novartis trial has positive read for Zura Bio, says Guggenheim
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100